Serum uric acid-lowering effect of sacubitril/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockers
Our findings indicate that switching from ARB to sacubitril/valsartan reduces serum uric acid levels in hypertensive patients and suggest that this uric acid-lowering effect may be associated with an increase in eGFR.
Authors
- Takeshi Horio (ORCID: https://orcid.org/0000-0002-2248-737X)
- Daiju Fukuda (ORCID: https://orcid.org/0009-0004-0270-7939)
- Yoshio Iwashima (ORCID: https://orcid.org/0000-0002-1932-7324)
- Kohei Fujimoto
- Takamasa Hasegawa
- Minoru Yoshiyama
Institutions
- Kansai Medical University (JP)
- Ishikiriseiki Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Blood Pressure Monitoring
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1097/mbp.0000000000000725
- Citations
- 3
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.02